Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trimetazidine 35mg modified-release tablets
0206020B0AAABAB
|
Trimetazidine hydrochloride | Trimetazidine hydrochloride | Cardiovascular System | 243 |
|
Trimetazidine 20mg tablets
0206020B0AAAAAA
|
Trimetazidine hydrochloride | Trimetazidine hydrochloride | Cardiovascular System | 10 |
|
Vastarel MR 35mg tablets
0206020B0BBABAB
|
Vastarel | Trimetazidine hydrochloride | Cardiovascular System | 7 |
|
Vastarel 20mg tablets
0206020B0BBAAAA
|
Vastarel | Trimetazidine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.